Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05839496
Other study ID # 730
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2, 2019
Est. completion date February 2, 2021

Study information

Verified date May 2023
Source Gazi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Headache is a common health problem. The most common headaches worldwide are migraine, tension-type headache (TTH), and cervicogenic headache (CGH). Due to the close anatomical relationship between the head and the cervical region, neck pain accompanies these headaches. The effects of cervical stabilization training including all of the cervical regions, thoracic regions, and the upper extremities in individuals with headaches are not yet known.


Description:

Headache is a common health problem. The most common headaches worldwide are migraine, tension-type headache (TTH), and cervicogenic headache (CGH). Due to the close anatomical relationship between the head and the cervical region, neck pain accompanies these headaches. Most of the previous studies examined the effects of exercise programs such as Cranio-Cervical Flexion Exercises (CCFE), posture exercises, muscle strengthening, and stretching exercises of the neck and shoulder on headaches. These studies presented the beneficial effects of CCFE which mostly targeted strengthening the superficial neck and shoulder muscles. However, the effects of cervical stabilization training including all of the cervical regions, thoracic regions, and the upper extremities in individuals with headaches are not yet known.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date February 2, 2021
Est. primary completion date January 2, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: 1. a clinical diagnosis of migraine, tension-type headache (TTH), and cervicogenic headache (CGH) 2. age between 18 and 55 years 3. being female 4. frequency of headaches at least once a week or more in the last year Exclusion Criteria: 1. having a neurological and orthopedic disease such as Parkinson's, stroke, cognitive disorders, and temporomandibular joint dysfunction, 2. having any contraindication for exercise, 3. having any serious head and/or neck trauma, 4. being with menopause, 5. being included in a physiotherapy program for head and neck pain in the last 12 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cervical stabilization exercises
Patients learned the activation of deep cervical flexor and extensor muscles. Then, during the activity of deep cervical muscles, superficial cervical muscles and upper extremity muscles were also strengthened. Thus, it was aimed to strengthen all neck muscles and upper extremity muscles in different positions synchronously and to increase their endurance.

Locations

Country Name City State
Turkey Gazi University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Gazi University

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia. 2015 Mar;35(3):211-9. doi: 10.1177/0333102414535110. Epub 2014 May 22. — View Citation

Castien R, De Hertogh W. A Neuroscience Perspective of Physical Treatment of Headache and Neck Pain. Front Neurol. 2019 Mar 26;10:276. doi: 10.3389/fneur.2019.00276. eCollection 2019. — View Citation

Edmondston SJ, Wallumrod ME, Macleid F, Kvamme LS, Joebges S, Brabham GC. Reliability of isometric muscle endurance tests in subjects with postural neck pain. J Manipulative Physiol Ther. 2008 Jun;31(5):348-54. doi: 10.1016/j.jmpt.2008.04.010. — View Citation

Fernandez-de-Las-Penas C, Florencio LL, Plaza-Manzano G, Arias-Buria JL. Clinical Reasoning Behind Non-Pharmacological Interventions for the Management of Headaches: A Narrative Literature Review. Int J Environ Res Public Health. 2020 Jun 9;17(11):4126. doi: 10.3390/ijerph17114126. — View Citation

Luedtke K, Basener A, Bedei S, Castien R, Chaibi A, Falla D, Fernandez-de-Las-Penas C, Gustafsson M, Hall T, Jull G, Kropp P, Madsen BK, Schaefer B, Seng E, Steen C, Tuchin P, von Piekartz H, Wollesen B. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity assessed by the VAS The average headache severity and neck pain severity in the last month was also assessed by using the Visual Analogue Scale (VAS). A Visual Analogue Scale (VAS) is one of the pain rating scales. A VAS consists of a line, often 10 cm long, with verbal anchors at either end (e.g., "no pain" on the far left and "the most intense pain imaginable" on the far right). The patient places a mark at a point on the line corresponding to the patient's rating of pain intensity. Eight weeks
Primary Forward head posture assessed by the craniovertebral angle To evaluate the cervical posture, pictures were taken from the side to objectively measure the forward head posture. Patients were asked to stand straight and then relax while the camera was placed at shoulder level. After printing the pictures, the craniovertebral angle was measured to represent the degree of forward head posture. This angle was calculated by measuring the angle between a horizontal line drawn through the 7th cervical vertebra and a line connecting the tragus of the ear and C7 spinous process. Eight weeks
Primary Deep cervical flexor muscles strength assessed by the stabilizer pressure biofeedback Cranio-Cervical Flexion Test : To begin the test, the patient is lying on a table in a supine position with their neck in a neutral position. A biofeedback stabilizer device is then placed under the patient's neck to rest against the occiput and inflated to a baseline pressure of 20 mmHg. During the test, the patient is asked to close their mouth with a slight gap between their jaws and place their tongue on the upper palate. They are then instructed to nod their head as if saying "yes." In the first stage of the test, the patient is asked to increase the pressure by 2 mmHg and maintain this position at 22 mmHg for 10 seconds. The patient is then asked to relax. In subsequent stages of the test, the pressure is reset to the initial pressure of 20 mmHg, and the patient is asked to perform the same head movement for 10 repetitions to create a pressure of 4, 6, 8, and 10 mmHg, respectively, and maintain the pressure for 10 seconds in each movement. Eight weeks
Primary Endurance of cervical muscles assessed by the chronometer During the endurance test of cervical flexors, the patient is lying supine position with the therapist's hand placed under their head. They are then asked to bring their chin closer to their chest, lifting their head about 2.5 cm and holding that position. The time they are able to maintain the position is recorded in seconds.
During the endurance test of cervical extensors, the patient is lying down with their heads bent downwards and their heads and chest hanging over the bed, with a 2-kg sandbag placed on the back of their necks. They are then asked to lift their heads to a neutral position and hold their position. The time they are able to maintain the position is recorded in seconds.
Eight weeks
Primary Cervical joint range of motion assessed by the cervical range of motion instrument The cervical joint range of motion was evaluated with a cervical joint range of motion measuring device. Active range of motion was measured in cervical flexion, extension, right rotation, left rotation, right lateral flexion, and left lateral flexion. Joint range of motion measurements were measured while the patient was sitting normally in an armless chair with a backrest. Eight weeks
Secondary Disability level (headache) assessed by migraine disability rating scale Migraine Disability Rating Scale: The Migraine Disability Assessment (MIDAS) questionnaire is a tool used to measure the impact of migraines on a person's daily life. It is a self-reported measure that assesses how much a person's headaches have affected their ability to perform daily activities, such as work, household chores, or social activities, over the past three months. The MIDAS questionnaire consists of five questions, with scores ranging from 0 to 270, and a higher score indicating a greater impact of migraine on daily activities.
The Migraine Disability Rating Scale (MIDAS) can be used to classify the severity of a person's migraines into one of four categories:
Grade I: Little or no disability, with a MIDAS score of 0-5. Grade II: Mild to moderate disability, with a MIDAS score of 6-10. Grade III: Moderate to severe disability, with a MIDAS score of 11-20. Grade IV: Severe disability, with a MIDAS score of more than 20.
Eight weeks
Secondary Disability level (neck pain) assessed by the neck disability index The Neck Disability Index (NDI): is a questionnaire that assesses the level of disability experienced by a person with neck pain. It was developed to measure the impact of neck pain on a person's ability to perform daily activities and to provide a standardized way of assessing disability due to neck pain. The NDI consists of 10 questions, each addressing a different aspect of daily life. The questions cover areas such as pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping, and recreation. The patient rates their level of disability for each question on a scale of 0 to 5, with 0 indicating no disability and 5 indicating complete disability. The scores for each question are then totaled. The maximum score is 50. The obtained score can be multiplied by 2 to produce a percentage score. Scoring intervals for interpretation, as follows:
0 - 4 = no disability 5 - 14 = mild 15 - 24 = moderate 25 - 34 = severe above 34 = complete.
Eight weeks
Secondary Health-related quality of life assessed by the short form 36 quality of life scale The Short Form 36 Quality of Life Scale (SF-36): is a self-reported questionnaire used to assess an individual's overall health-related quality of life. It includes 36 questions and covers eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. To score the SF-36, scales are standardized with a scoring algorithm to obtain a score ranging from 0 to 100. Higher scores indicate better health status and a mean score of 50 has been articulated as a normative value for all scales. Eight weeks
Secondary Sleep quality assessed by the Pittsburgh sleep quality index The Pittsburgh Sleep Quality Index (PSQI): is a self-reported questionnaire that assesses an individual's sleep quality and disturbances over a one-month time period. The questionnaire consists of 19 questions that are grouped into seven categories: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each category is scored on a scale of 0 to 3, with 3 indicating the greatest sleep disturbance. The seven category scores are then summed to produce a global PSQI score, which ranges from 0 to 21. A score of 5 or greater indicates poor sleep quality, while a score of 8 or greater is considered a severe sleep disturbance. The PSQI has been used in research studies and clinical settings to evaluate sleep quality and to identify individuals who may benefit from interventions to improve their sleep. Eight weeks
Secondary Mood assessed by the Beck depression inventory The Beck Depression Inventory (BDI): is a self-report questionnaire that measures the severity of depression in individuals. The BDI consists of 21 questions or items, each of which has four possible responses. The questions cover a range of symptoms commonly associated with depression, such as sadness, loss of interest in activities, feelings of worthlessness or guilt, changes in appetite or sleep, and thoughts of self-harm. The responses are scored on a scale from 0 to 3, with higher scores indicating more severe depression. The total score ranges from 0 to 63, with scores of 0-9 indicating minimal depression, scores of 10-18 indicating mild depression, scores of 19-29 indicating moderate depression, and scores of 30 or higher indicating severe depression. Eight weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT03472872 - A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache Phase 4
Withdrawn NCT05410366 - Safe Harbors in Emergency Medicine, Specific Aim 3
Withdrawn NCT02866084 - Neuromodulation Treatment of Vestibular Migraines N/A
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Not yet recruiting NCT04352218 - Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache Phase 2
Completed NCT02734992 - Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers N/A
Completed NCT01153789 - Study of Oculomotor Dysfunction Leading to Children Vertigo N/A
Completed NCT01327118 - Prostaglandin F2alpha in a Human Headache Model N/A
Not yet recruiting NCT00969995 - Identification of Inflammatory Markers in Migraine Patients N/A
Not yet recruiting NCT00752921 - Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache Phase 4
Completed NCT00212810 - Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. Phase 4
Terminated NCT00291395 - PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers Phase 1
Completed NCT00263094 - An End to the Yom Kippur (and Ramadan) Headache N/A
Completed NCT00135122 - Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache Phase 3
Completed NCT02475005 - An Intervention to Improve Adolescent Headache Self-management N/A
Completed NCT03163901 - The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury N/A
Completed NCT01664585 - Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life N/A
Completed NCT04632420 - Evaluation of Headache and Childbirth in a Chronic Pain Population
Recruiting NCT05033613 - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease